DOES EXIST DEPENDENCE OF DOSE VALUES IN ORGANS OF RISK (OAR) AND PROGNOSTIC FACTORS UNDER HDR BRACHYTHERAPY (HDR-BT) OF PROSTATE CANCER?

被引：0
|
作者：
Skowronek, J. [1 ]
Chichel, A. [1 ]
Kanikowski, M. [1 ]
Zwierzchowski, G. [2 ]
机构：
[1] Greatpoland Canc Ctr, Brachytherapy, Poznan, Poland
[2] Greatpoland Canc Ctr, Dept Med Phys, Poznan, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2009年 / 91卷
关键词：
D O I：
10.1016/S0167-8140(15)34399-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] DOES THE CHOICE OF BRACHYTHERAPY TECHNIQUES (HDR, LDR) INFLUENCE THE RELATIONSHIP BETWEEN DOSE VALUES AND PROGNOSTIC FACTORS IN THE TARGET AND ORGANS AT RISK IN THE TREATMENT OF PROSTATE CANCER?
    Skowronek, J.
    Zwterzchowski, G.
    Chichel, A.
    Kanikowski, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : XXIV - XXV
  • [2] RELATIONSHIP BETWEEN TREATMENT PLAN PARAMETERS AND PARTICULAR PROGNOSTIC FACTORS IN PROSTATE CANCER TREATED WITH HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) AS A BOOST.
    Chichel, A.
    Kanikowski, M.
    Skowronek, J.
    Dymnicka, M.
    Piotrowski, T.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S339 - S339
  • [3] Analysis of Volume Based GYN HDR Brachytherapy Plans for Dose Calculation to Organs At Risk(OAR)
    Nair, M.
    Li, C.
    White, M.
    Davis, J.
    MEDICAL PHYSICS, 2014, 41 (06) : 374 - 374
  • [4] HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) COMBINED WITH EXTERNAL BEAM RADIATION THERAPY (EBRT) IN PATIENTS WITH PROSTATE CANCER
    Inomata, T.
    Shimbo, T.
    Takahashi, M.
    Uesugi, Y.
    Azuma, H.
    Katsuoka, Y.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S327 - S327
  • [5] Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer
    Rades, Dirk
    Schwarz, Rudolf
    Todorovic, Manuel
    Thurmann, Horst
    Graefen, Markus
    Walz, Jochen
    Schild, Steven E.
    Dunst, Juergen
    Alberti, Winfried
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (07) : 398 - 402
  • [6] Combining EBRT and HDR-BT in high-risk prostate cancer: an effective and safe experience
    Candini, D.
    Lopez-Campos, F.
    Munoz, T.
    Martin, M.
    Vallejo, C.
    Hervas, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S831 - S831
  • [7] High dose rate brachytherapy (HDR-BT) as monotherapy for favorable prostate cancer: Excellent 5-year control rates and low toxicity
    Demanes, D. J.
    Gilhezan, M.
    Schour, L.
    Gustafson, G.
    Hill, D. R.
    Marvin, K.
    Bernstein, I.
    Martinez, A. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S83 - S83
  • [8] Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer
    Galalae, RM
    Martinez, A
    Mate, T
    Mitchell, C
    Edmundson, G
    Nuernberg, N
    Eulau, S
    Gustafson, G
    Gribble, M
    Kovács, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04): : 1048 - 1055
  • [9] Single dose HDR brachytherapy is safe for low-risk prostate cancer
    Hoskin, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S39 - S39
  • [10] Palliative combined treatment by high-dose-rate brachytherapy (HDR-BT) and stents in patients with esophageal cancer.
    Kanikowski, M.
    Skowronek, J.
    Clichel, A.
    Kubaszewska, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S269 - S269
12345